Tenaya Therapeutics, Inc. (TNYA) stock
TNYANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.31−0.02 (-4.93%)
Close on Nov 18, 2026Market cap $68.82MP/E –Yield –
Tenaya Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Tenaya Therapeutics's price to book ratio was 1.2× on Nov 11, 2026, against 2.2× a year earlier. Over the last 4 years it ranged from 0.3× to 2.9×, with a median of 1.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.2× | +0.1 |
| 2025 | Dec 31, 2025 | 1.1× | +0.1 |
| 2024 | Dec 31, 2024 | 1.0× | −0.3 |
| 2023 | Dec 29, 2023 | 1.4× | −0.0 |
| 2022 | Apr 29, 2022 | 1.4× | +0.9 |
| 2021 | Dec 31, 2021 | 0.5× | – |
See a number that looks wrong?